Thromb Res 2020 09 17;193:166-169. Epub 2020 Jul 17.
Division of Cardiovascular Medicine, Nouvel Hôpital Civil, Strasbourg University Hospital, Strasbourg, France; INSERM (French National Institute of Health and Medical Research), UMR 1260, Regenerative Nanomedicine, FMTS, Strasbourg, France. Electronic address:
Eye Contact Lens 2021 May 11. Epub 2021 May 11.
Departments of Innovative Visual Science (S.K.), and Ophthalmology (S.K.), Osaka University Graduate School of Medicine, Osaka, Japan; and Department of Ophthalmology (M.K.R.), Icahn School of Medicine at Mount Sinai, New York, NY.
Abstract: The aim of this article is to review the literature on the impact of coronavirus disease 2019 (COVID-19) on dry eye disease (DED). A literature search on dry eye and COVID-19 was performed. Most current studies focus on DED in patients diagnosed with COVID-19 or dry eye symptoms in random populations of students and medical staff. Read More
Eur J Cancer Prev 2021 May 7. Epub 2021 May 7.
Oncology Unit, Medical Oncology & Hematology Department, Humanitas Clinical and Research Center - IRCCS, Rozzano Department of Biomedical Sciences, Humanitas University Department of Radiology Thoracic Surgery Unit, Surgery Department Sarcoma, Melanoma and Rare Tumors Surgery Unit, Surgery Department, Humanitas Clinical and Research Center-IRCCS, Rozzano, Italy.
Psychiatry Res 2021 Apr 26;301:113966. Epub 2021 Apr 26.
From the Department of Psychiatry and Human Behavior, Brown Medical School, and the Department of Psychiatry, Rhode Island Hospital, 146 West River Street, Providence, RI 02904.
Most research evaluating telehealth psychiatric treatment has been conducted in outpatient settings. There is a lack of research assessing the efficacy of telehealth treatment in more acute, intensive treatment settings such as a partial hospital. In the face of the COVID-19 pandemic, much of ambulatory behavioral health treatment has transitioned to a telehealth, or virtual, format. Read More
Mult Scler Relat Disord 2021 May 4;52:102983. Epub 2021 May 4.
Unit of Neurology, IRCCS Neuromed, Pozzilli (Is), Italy.
Since the recent approval of vaccines against COVID-19, efficacy concerns emerged for MS patients treated with immunosuppressive drugs. We report our experience in four patients, under cladribine (two) or under ocrelizumab (two) treatment, all with low lymphocyte count, three of them vaccinated after 3 months from the last dose with good immune response, one (under ocrelizumab) after 2 months, without developing an appropriate title of antibodies. This experience suggests that the discriminant for the response to the vaccine is not the lymphocyte count but the timing of the vaccination. Read More
J Crit Care 2021 May 1;64:199-204. Epub 2021 May 1.
Service de Médecine intensive et réanimation, Hôpital Ambroise Paré, Assistance Publique Hôpitaux de Paris, France; INSERM UMR 1018, Clinical Epidemiology Team, CESP, Université de Paris Saclay, Villejuif, France. Electronic address:
Purpose: Studies performed in spontaneously breathing patients with mild to moderate respiratory failure suggested that prone position (PP) in COVID-19 could be beneficial.Materials And Methods: Consecutive critically ill patients with COVID-19 were enrolled in four ICUs. PP sessions lasted at least 3 h each and were performed twice daily. Read More